Stanley Leon Hazen MD
Endocrinology
Professor, Molecular Medicine, Case Western Reserve University School of Medicine. Preventative Cardiology
Join to View Full Profile
9500 Euclid Ave# Jb1Cleveland, OH 44195
Phone+1 800-223-2273
Dr. Hazen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1996
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1992 - 1994
- Washington University in St. Louis School of MedicineClass of 1992
Certifications & Licensure
- OH State Medical License 1997 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Elected Member The American Society for Clinical Investigation, 2003
- Fellow (FACC) American College of Cardiology
Clinical Trials
Publications & Presentations
PubMed
- Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis.Vanasa Nageswaran, Alba Carreras, Leander Reinshagen, Katharina R Beck, Jakob Steinfeldt
Arteriosclerosis, Thrombosis, and Vascular Biology. 2025-03-27 - Xylitol and cardiovascular risks.Marco Witkowski, Stanley L Hazen
European Heart Journal. 2025-03-11 - Abbreviated Duke Activity Status Index for Risk Stratification in Heart Failure.Silvio Nunes Augusto Jr, Yuping Wu, Thanat Chaikijurajai, Stanley L Hazen, W H Wilson Tang
The American Journal of Cardiology. 2025-02-15
Journal Articles
- Dietary Metabolism, the Gut Microbiome, and Heart FailureStanley L Hazen, Daniel Y Li, Nature
- Development of a Gut Microbe–Targeted Nonlethal Therapeutic to Inhibit Thrombosis PotentialStanley Hazen, MD, Nature
- Elevated Levels of Plasma Symmetric Dimethylarginine and Increased Arginase Activity as Potential Indicators of Cardiovascular Comorbidity in Rheumatoid ArthritisStanley Hazen, MD, BioMed Central
- Join now to see all
Press Mentions
- Medical Minute: Long-Term Heart Risks from COVID-19March 18th, 2025
- Xylitol Linked to Increased Blood Clot RiskMarch 11th, 2025
- Unexpected Aftermath: The COVID HeartFebruary 4th, 2025
- Join now to see all
Grant Support
- Artificial sweeteners and cardiovascular diseaseCLEVELAND CLINIC LERNER COM-CWRU2025–2028
- Nutrition, terminal NAD metabolites and cardiovascular diseaseCLEVELAND CLINIC LERNER COM-CWRU2024–2028
- Aromatic Amino Acids, Microbiome-Generated Metabolites, and Incident Subclinical and Clinical CVD and MortalityTUFTS UNIVERSITY BOSTON2017–2028
- Gut microbial dietary phenylalanine metabolism and heart failureCLEVELAND CLINIC LERNER COM-CWRU2024–2027
- Gut microbial dietary phenylalanine metabolism and heart failureCLEVELAND CLINIC LERNER COM-CWRU2024–2027
- Gut Microbiota and Cardiometabolic DiseasesCLEVELAND CLINIC LERNER COM-CWRU2019–2025
- Gut Flora metabolism of dietary carnitine and cardiovascular diseaseCLEVELAND CLINIC LERNER COM-CWRU2010–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: